Search

everythinglearnresearchcommunity

for

Search:↓

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

Patients treated with long-term intralesional corticosteroids for alopecia areata should be monitored for bone density changes and advised on osteoporosis prevention.

Balding men had lower bone density, while balding women had higher hip bone density.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Collagen with calcium and vitamin D improves bone health, skin elasticity, and reduces hair loss in menopausal women.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Mice with CBS deficiency are healthier on a low-methionine diet.

Finasteride can cause sexual dysfunction, sperm changes, and affect bone density and metabolism.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

Two siblings with a genetic mutation had a form of rickets that doesn't respond to vitamin D.

Some cancer treatments can cause permanent hair loss.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

Methionine restriction works better than betaine for treating CBS deficiency symptoms in mice.

Higher free testosterone levels can increase bone density and decrease body fat but may raise the risk of prostate cancer, hair loss, and benign prostate enlargement.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

Finasteride doesn't affect bone density in male rats.

Stem cell treatments show promise for hair loss but need more research.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

A hormone linked to collagen helps hair grow back in mice after chemotherapy, and may also prevent bone loss.

A girl with lupus and trisomy X has a higher risk of bone problems like avascular necrosis and osteoporosis.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

Autologous stem cell therapy may effectively increase hair density in Androgenetic Alopecia.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Early phosphorus-calcium disorders in children with chronic kidney disease can lead to bone issues, highlighting the need for early bone density testing.

Stem cell therapy shows promise for treating hair loss.